Two Red Rock pharmacy locations have resolved citations, Empower Pharmacy has a dodgy inspection history, and the BBB has flagged eight unanswered complaints
Both drugs have side effects like irritability, insomnia, headache, nervousness, and palpitations and are restricted to short-term use (less than 12 weeks)
Large-scale cardiovascular outcome trials, including the SUSTAIN programme, have monitored safety parameters including fractures as adverse events
Moreover, based on their pharmacokinetic/pharmacodynamic profile, GLP-1RAs can be classified into short-acting (exenatide and lixisenatide) and long-acting (albiglutide, dulaglutide, exenatide extended-release, liraglutide, semaglutide, and efpeglenatide) [5, 6]